Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Opko Health reports transfer of licensed rights to RAYALDEE in Japan to Vifor » 07:32
05/24/21
05/24
07:32
05/24/21
07:32
OPK

Opko Health

$3.66 /

-0.035 (-0.95%)

, JAPAY

Japan Tobacco

$9.96 /

-0.0201 (-0.20%)

, GNHAF

Vifor Pharma

$139.36 /

+ (+0.00%)

OPKO Health (OPK)…

OPKO Health (OPK) announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco (JAPAY) to Vifor Fresenius Medical Care Renal Pharma (GNHAY). On May 17, 2021, JT notified OPKO of its decision to terminate the exclusive agreement with OPKO's subsidiary, EirGen Pharma, Ltd., for the development and commercialization of RAYALDEE in Japan based on a comprehensive review of its development pipeline. Concurrently with the termination of JT's rights, EirGen and VFMCRP have agreed to transfer the rights to RAYALDEE in Japan to VFMCRP by including Japan into the existing exclusive agreement between the two companies, executed on May 9, 2016, for the development and commercialization of RAYALDEE in Europe and certain other international markets for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease and vitamin D insufficiency.

ShowHide Related Items >><<
OPK Opko Health
$3.66 /

-0.035 (-0.95%)

GNHAF Vifor Pharma
$139.36 /

+ (+0.00%)

OPK Opko Health
$3.66 /

-0.035 (-0.95%)

02/19/21 Barrington
Opko Health price target raised to $8 from $7 at Barrington
07/31/20 Piper Sandler
Opko Health price target raised to $10 from $6 at Piper Sandler
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
06/09/20 Piper Sandler
Opko Health price target raised to $4 from $3 at Piper Sandler
JAPAY Japan Tobacco
$9.96 /

-0.0201 (-0.20%)

04/20/21 Citi
Biden bill would be 'severe blow' to tobacco, says Citi
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
03/10/21 JPMorgan
Japan Tobacco downgraded to Neutral from Overweight at JPMorgan
07/27/20 Citi
Citi opens '30-day negative catalyst watch' for Japan Tobacco
GNHAF Vifor Pharma
$139.36 /

+ (+0.00%)

03/01/21 UBS
Vifor Pharma upgraded to Neutral from Sell at UBS
02/10/21 Barclays
Vifor Pharma price target lowered to CHF 120 from CHF 140 at Barclays
01/22/21 UBS
Vifor Pharma downgraded to Sell from Neutral at UBS
01/22/21 UBS
Vifor Pharma downgraded to Sell from Neutral at UBS
OPK Opko Health
$3.66 /

-0.035 (-0.95%)

OPK Opko Health
$3.66 /

-0.035 (-0.95%)

OPK Opko Health
$3.66 /

-0.035 (-0.95%)

Recommendations
Biden bill would be 'severe blow' to tobacco, says Citi » 05:45
04/20/21
04/20
05:45
04/20/21
05:45
PM

Philip Morris

$91.63 /

-1.29 (-1.39%)

, MO

Altria Group

$49.08 /

-3.23 (-6.17%)

, IMBBY

Imperial Brands

$21.65 /

-0.26 (-1.19%)

, JAPAY

Japan Tobacco

$9.62 /

+0.06 (+0.63%)

The Biden administration…

The Biden administration considering cutting almost all nicotine from cigarettes and banning menthol would be a "severe blow" to tobacco, Citi analyst Adam Spielman tells investors in a research note. However it is not yet clear that the administration will actually bring such proposals forward, says the analyst. In theory, a rule to make cigarettes non-addictive could have a "severe impact," but a bill would unlikely be implemented for many years, notes Spielman.

ShowHide Related Items >><<
PM Philip Morris
$91.63 /

-1.29 (-1.39%)

MO Altria Group
$49.08 /

-3.23 (-6.17%)

IMBBY Imperial Brands
$21.65 /

-0.26 (-1.19%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
MO Altria Group
$49.08 /

-3.23 (-6.17%)

03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Jefferies
Altria Group upgraded to Buy from Hold at Jefferies
03/19/21 Deutsche Bank
Altria Group price target raised to $54 from $52 at Deutsche Bank
03/16/21
Fly Intel: Top five analyst downgrades
IMBBY Imperial Brands
$21.65 /

-0.26 (-1.19%)

03/26/21 Jefferies
Imperial Brands downgraded to Hold from Buy at Jefferies
02/08/21 Morgan Stanley
Imperial Brands price target raised to 1,630 GBp at Morgan Stanley
01/29/21 Citi
Imperial Brands downgraded to Neutral from Buy at Citi
JAPAY Japan Tobacco
$9.62 /

+0.06 (+0.63%)

03/10/21 JPMorgan
Japan Tobacco downgraded to Neutral from Overweight at JPMorgan
07/27/20 Citi
Citi opens '30-day negative catalyst watch' for Japan Tobacco
PM Philip Morris
$91.63 /

-1.29 (-1.39%)

MO Altria Group
$49.08 /

-3.23 (-6.17%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

MO Altria Group
$49.08 /

-3.23 (-6.17%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

MO Altria Group
$49.08 /

-3.23 (-6.17%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

MO Altria Group
$49.08 /

-3.23 (-6.17%)

Recommendations
Last U.S. cigarette smoker like to quit by 2050, says Citi » 06:59
03/16/21
03/16
06:59
03/16/21
06:59
PM

Philip Morris

$87.64 /

-0.13 (-0.15%)

, BTI

British American Tobacco

$37.62 /

+0.14 (+0.37%)

, MO

Altria Group

$49.83 /

+1.17 (+2.40%)

, IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

, JAPAY

Japan Tobacco

$0.00 /

+ (+0.00%)

Citi analyst Adam…

Citi analyst Adam Spielman believes it is likely that the last cigarette smoker will have quit by 2050 in the U.S. and many other markets. However, not all markets look like this, the analyst points out. Reduced-risk products appear to have slowed or even halted the decline in some markets, Spielman tells investors in a research note. As such, the analyst thinks there is an "increasing gap opening up" between the companies leading the move to RRPs, namely Philip Morris (PM), British American Tobacco (BTI) and KT&G, and the others. Spielman thinks the tobacco shares are undervalued now. Tobacco valuations would be justified if their entire business was likely to expire in 2050, but their exposure to RRPs, and to traditional markets with slower declines, means this looks conservative, especially for companies gaining share with RRPs, says the analyst. Spielman re-emphasized Buy ratings on Philip Morris, British American Tobacco and KT&G, and downgraded Altria Group (MO) to Neutral from Buy. He keeps Neutral ratings on Imperial Brands (IMBBY) and Japan Tobacco (JAPAY).

ShowHide Related Items >><<
PM Philip Morris
$87.64 /

-0.13 (-0.15%)

MO Altria Group
$49.83 /

+1.17 (+2.40%)

BTI British American Tobacco
$37.62 /

+0.14 (+0.37%)

PM Philip Morris
$87.64 /

-0.13 (-0.15%)

02/11/21 Citi
Philip Morris shares have 'significant upside,' says Citi
02/05/21 Stifel
Philip Morris price target raised to $100 from $90 at Stifel
01/19/21 Bernstein
Philip Morris initiated with a Market Perform at Bernstein
01/08/21 Citi
Citi 'very bullish' on Philip Morris, ups price target to $105
BTI British American Tobacco
$37.62 /

+0.14 (+0.37%)

03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/11/21 Cantor Fitzgerald
Organigram price target raised to C$6 from C$3.50 at Cantor Fitzgerald
02/19/21 Morgan Stanley
British American Tobacco price target lowered to 3,130 GBp from 3,330 GBp at Morgan Stanley
02/18/21 Societe Generale
British American Tobacco price target lowered to 3,570 GBp from 3,800 GBp at Societe Generale
MO Altria Group
$49.83 /

+1.17 (+2.40%)

03/16/21 Citi
Altria Group downgraded to Neutral from Buy at Citi
01/21/21 Goldman Sachs
Altria price increase doesnt address ongoing concerns, says Goldman Sachs
01/19/21 Bernstein
Altria Group initiated with an Outperform at Bernstein
12/15/20 RBC Capital
Altria's R.J. Reynolds, Santa Fe Natural increasing prices, says RBC Capital
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

02/08/21 Morgan Stanley
Imperial Brands price target raised to 1,630 GBp at Morgan Stanley
01/29/21 Citi
Imperial Brands downgraded to Neutral from Buy at Citi
01/28/21 JPMorgan
Imperial Brands price target raised to 2,000 GBp from 1,900 GBp at JPMorgan
01/19/21 Credit Suisse
Imperial Brands price target lowered to 2,170 GBp at Credit Suisse
JAPAY Japan Tobacco
$0.00 /

+ (+0.00%)

03/10/21 JPMorgan
Japan Tobacco downgraded to Neutral from Overweight at JPMorgan
07/27/20 Citi
Citi opens '30-day negative catalyst watch' for Japan Tobacco
PM Philip Morris
$87.64 /

-0.13 (-0.15%)

MO Altria Group
$49.83 /

+1.17 (+2.40%)

MO Altria Group
$49.83 /

+1.17 (+2.40%)

PM Philip Morris
$87.64 /

-0.13 (-0.15%)

MO Altria Group
$49.83 /

+1.17 (+2.40%)

BTI British American Tobacco
$37.62 /

+0.14 (+0.37%)

PM Philip Morris
$87.64 /

-0.13 (-0.15%)

MO Altria Group
$49.83 /

+1.17 (+2.40%)

Downgrade
Japan Tobacco downgraded to Neutral from Overweight at JPMorgan » 05:33
03/10/21
03/10
05:33
03/10/21
05:33
JAPAY

Japan Tobacco

$0.00 /

+ (+0.00%)

JPMorgan analyst Ritsuko…

JPMorgan analyst Ritsuko Tsunoda downgraded Japan Tobacco to Neutral from Overweight with a 2,100 yen price target.

ShowHide Related Items >><<
JAPAY Japan Tobacco
$0.00 /

+ (+0.00%)

07/27/20 Citi
Citi opens '30-day negative catalyst watch' for Japan Tobacco

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.